Skip to main content
Top

2013 | OriginalPaper | Hoofdstuk

30. Dementie

Auteurs : dr. J.A.H.R. Claassen, prof. dr. F.R.J. Verhey, prof. dr. M.G.M. Olde Rikkert

Gepubliceerd in: Het geriatrie formularium

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Artsen hebben in meer dan één opzicht te maken met dementie waar het gaat om hun geneesmiddelenbeleid. Er is een aantal situaties te onderscheiden.
Literatuur
1.
go back to reference Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011;378:403-11.PubMedCrossRef Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet 2011;378:403-11.PubMedCrossRef
2.
go back to reference Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE. Rivastigminefor Alzheimer’s disease. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001191. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE. Rivastigminefor Alzheimer’s disease. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001191.
3.
go back to reference Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer’s disease. Am J Med 2007;120:388-97.PubMedCrossRef Farlow MR, Cummings JL. Effective pharmacologic management of Alzheimer’s disease. Am J Med 2007;120:388-97.PubMedCrossRef
4.
go back to reference Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. NEJM 2012;366: 893-903.PubMedCrossRef Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. NEJM 2012;366: 893-903.PubMedCrossRef
5.
go back to reference Iliffe S. The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer’s disease. CNS Drugs 2007; 21:177-84.PubMedCrossRef Iliffe S. The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer’s disease. CNS Drugs 2007; 21:177-84.PubMedCrossRef
6.
go back to reference Jann MW, Shirley KL, Small GW. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin Pharmacokinet 2002;41:719-39.PubMedCrossRef Jann MW, Shirley KL, Small GW. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin Pharmacokinet 2002;41:719-39.PubMedCrossRef
7.
go back to reference Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord 2007;23:351-67.PubMedCrossRef Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord 2007;23:351-67.PubMedCrossRef
8.
go back to reference Overshott R, Karim S, Burns A. Cholinesterase-inhibitors for delirium. Cochrane Database Syst Rev. 2008;(1):CD005317. Overshott R, Karim S, Burns A. Cholinesterase-inhibitors for delirium. Cochrane Database Syst Rev. 2008;(1):CD005317.
9.
go back to reference Richard E, Heuvel E van den, Moll van Charante EP, Achthoven L, Vermeulen M, Bindels PJ, et al. Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord. 2009;23:198-204.PubMedCrossRef Richard E, Heuvel E van den, Moll van Charante EP, Achthoven L, Vermeulen M, Bindels PJ, et al. Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress. Alzheimer Dis Assoc Disord. 2009;23:198-204.PubMedCrossRef
10.
go back to reference Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase-inhibitors for DLB, PDD and CIND-PD. Cochrane Database Syst Rev 2012;3: CD006504. Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase-inhibitors for DLB, PDD and CIND-PD. Cochrane Database Syst Rev 2012;3: CD006504.
Metagegevens
Titel
Dementie
Auteurs
dr. J.A.H.R. Claassen
prof. dr. F.R.J. Verhey
prof. dr. M.G.M. Olde Rikkert
Copyright
2013
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-9265-0_30